What are you looking for?
Showing the single result
Filter
Selexipag Tablets (200 mcg / 400 mcg / 600 mcg / 800 mcg)
Selexipag is a prescription-only, selective prostacyclin receptor agonist made to manage Pulmonary Arterial Hypertension (PAH, WHO Group 1). It targets particular receptors in the vascular walls, helping slow overall illness worsening, improve everyday walking and exertion tolerance, and lower the chance of needing hospitalization.
Therapeutic Class: Cardiovascular / Antihypertensives
Pharmacological Class: Non-Prostanoid Prostacyclin Receptor (IP Receptor) Agonist
Available Strengths: 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1000 mcg, 1200 mcg, 1400 mcg, and 1600 mcg
Film-Coated Tablets
Prescription Required: Yes (Rx Only)
Habit Forming: No
Key Benefits of Selexipag Therapy
1. Opens Tight Pulmonary Arteries
In people with PAH, the vessels that carry blood from the right side of the heart to the lungs become dangerously thick and stiff. Selexipag helps relax and widen these lung arteries, lowering internal resistance so your heart can move blood with less strain.
2. Helps Delay Long-Term Disease Progression
Clinical evaluations suggest that consistent, long-term use of Selexipag can reduce worsening of cardiovascular symptoms, keeping functional capacity closer to baseline and supporting continued activity.
3. Cuts Down Emergency Hospital Re-Visits
By supporting steadier, reduced arterial pressures within the breathing circuit, this treatment may help protect vulnerable patients from critical strain episodes that lead to emergency admission.
How It Works
Selexipag is an oral prodrug. After you take it, specific liver enzymes convert it into the active metabolite, roughly 37-fold stronger. Unlike older synthetic prostanoids, Selexipag is highly selective for prostacyclin IP receptors on human smooth muscle cells. Once activated, it raises cyclic adenosine monophosphate (cAMP) levels, leading to three main effects: strong vasodilation, reduced platelet clumping (low clotting aggregation), and less risk of vascular scarring, thickening, or remodeling.
Directions for Use and Dosing Regimen
How to Take
Swallow the tablet whole with plain water. Do not break, crush, chew, or split the tablet.
Food Guidance
Taking your dose with food or a snack is strongly suggested. Food does not change the total amount absorbed, but it slows the concentration peak, which often improves day-to-day tolerability.
Titration Stage
Most patients start with 200 mcg twice daily (about 12 hours apart). Under careful clinician guidance, the prescriber increases the dose by 200 mcg twice daily each week until you reach your personal, highest tolerated maintenance level.
Missed Dose Rule
If you forget a dose, take it as soon as you remember. If your next dose is less than 6 hours away, skip the missed one completely. Never take a double dose.
Possible Side Effects
Because Selexipag promotes vasodilation across the body, short-lived side effects are common, especially during the early weekly dose-escalation phase.
Common Side Effects (often manageable with symptomatic treatment)
- Headaches (the most frequently reported)
- Jaw pain or facial flushing
- Diarrhea, nausea, or mild vomiting
- Muscle pain (myalgia) or localized limb pain
Rare or Serious Warnings (seek help right away)
- Sudden, severe dizziness or a rapid fall in blood pressure (hypotension)
- Indicators of hyperthyroidism, such as an unexplained fast heartbeat or sudden weight loss
- Severe anemia, or swelling (edema) in the lower legs
Safety Warnings & Drug Contraindications
Patient Profile / Safety Assessment
Clinical Directive Note
Alcohol Consumption ⚠️ Caution Use
Alcohol can intensify vasodilatory effects, making dizziness, fainting, or severe headaches more likely.
Pregnancy ❌ Avoid
Limited human information is available. Animal work indicates possible reproductive harm. Discuss with your specialist so the benefit vs. risk balance is clear.
Breastfeeding ❌ Not Recommended
It is unknown whether Selexipag enters human breast milk. If you are lactating, talk about alternative treatments, or consider stopping nursing.
CYP2C8 Drug Interactions ❌ Contraindicated
Avoid strong CYP2C8 inhibitors such as Gemfibrozil entirely. Using them can greatly increase Selexipag levels, raising the risk of severe toxicity.
Hepatic Impairment ⚠️ High Caution
Use is acceptable in mild liver disease. In moderate impairment (Child-Pugh Class B) a modified, once-daily dosing rhythm is needed. Do not use in severe liver impairment.
Frequently Asked Questions (FAQs)
Q. Is Selexipag a type of blood pressure medication?
It is an antihypertensive medicine, but it is not a standard option for systemic hypertension (high blood pressure typically measured in the arm). Selexipag acts on pulmonary arteries between the heart and lungs, lowering pressure in the respiratory circuit by working on specific internal cellular receptors.
Q. What if side effects become unbearable during dose increases?
Jaw pain, headaches, and diarrhea can be signs the drug is actively affecting your blood vessels. If the symptoms become too intense while titrating, do not abruptly stop the medication. Call your treating doctor; they may advise reducing back to the previous week’s dose you tolerated, then trying titration again later.
Q. If I travel and miss Selexipag for a few days, what happens?
Stopping therapy can trigger a harmful rebound rise in pulmonary arterial pressure. If you miss Selexipag for 3 consecutive days or more, do not restart your usual maintenance schedule. Contact your doctor immediately. You will likely need to restart at the lowest baseline dose (200 mcg twice daily) and then titrate upward slowly.
Q. Can I switch from oral Selexipag tablets to an intravenous (IV) version?
There is an IV formulation, but it is generally reserved for brief hospital situations when a person cannot swallow tablets temporarily, like soon after surgery. The hospital team will compute the precise microgram-to-milligram conversion needed to match your current oral maintenance dose.
